Foamix Pharmaceuticals Ltd. Pre-Tax Income
Foamix Pharmaceuticals Ltd. reported Pre-Tax Income of -$95.35 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2020-03-12
- Foamix Pharmaceuticals Ltd. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2019-12-31 was -$37.82M.
- Foamix Pharmaceuticals Ltd. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2019-09-30 was -$23.16M.
- Foamix Pharmaceuticals Ltd. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2019-06-30 was -$18.99M.
- Foamix Pharmaceuticals Ltd. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2019-03-31 was -$15.38M.
- Foamix Pharmaceuticals Ltd. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2019 was -$95.35M.
- Foamix Pharmaceuticals Ltd. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2018 was -$73.95M.
- Foamix Pharmaceuticals Ltd. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2017 was -$64.55M.
- Foamix Pharmaceuticals Ltd. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2016 was -$28.95M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$37.82M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$60.98M derived: sum of 2 quarters · filed 2020-03-12 | -$79.97M derived: sum of 3 quarters · filed 2020-03-12 | -$95.35M 10-K · filed 2020-03-12 |
| 2019-09-30 | -$23.16M 10-Q · filed 2019-11-12 | -$42.15M derived: sum of 2 quarters · filed 2019-11-12 | -$57.53M 10-Q · filed 2019-11-12 | -$71.86M derived: sum of 4 quarters · filed 2020-03-12 |
| 2019-06-30 | -$18.99M 10-Q · filed 2019-08-07 | -$34.37M 10-Q · filed 2019-08-07 | -$48.70M derived: sum of 3 quarters · filed 2020-03-12 | -$64.17M derived: sum of 4 quarters · filed 2020-03-12 |
| 2019-03-31 | -$15.38M 10-Q · filed 2019-05-07 | -$29.71M derived: sum of 2 quarters · filed 2020-03-12 | -$45.18M derived: sum of 3 quarters · filed 2020-03-12 | -$63.68M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-12-31 | -$14.33M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$29.80M derived: sum of 2 quarters · filed 2020-03-12 | -$48.30M derived: sum of 3 quarters · filed 2020-03-12 | -$73.95M 10-K · filed 2020-03-12 |
| 2018-09-30 | -$15.47M 10-Q · filed 2019-11-12 | -$33.98M derived: sum of 2 quarters · filed 2019-11-12 | -$59.62M 10-Q · filed 2019-11-12 | -$76.03M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | -$18.51M 10-Q · filed 2019-08-07 | -$44.16M 10-Q · filed 2019-08-07 | -$60.56M derived: sum of 3 quarters · filed 2020-03-12 | -$78.09M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | -$25.65M 10-Q · filed 2019-05-07 | -$42.05M derived: sum of 2 quarters · filed 2020-03-12 | -$59.58M derived: sum of 3 quarters · filed 2020-03-12 | -$75.89M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | -$16.41M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$33.93M derived: sum of 2 quarters · filed 2020-03-12 | -$50.24M derived: sum of 3 quarters · filed 2020-03-12 | -$64.55M 10-K · filed 2020-03-12 |
| 2017-09-30 | -$17.53M 10-Q · filed 2018-11-07 | -$33.83M derived: sum of 2 quarters · filed 2018-11-07 | -$48.15M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | -$16.31M 10-Q · filed 2018-08-08 | -$30.62M 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | -$14.31M 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | -$28.95M 10-K · filed 2019-02-28 | |||
| 2016-06-30 | -$8.14M 6-K · filed 2017-08-08 | -$12.52M 6-K · filed 2017-08-08 | ||
| 2015-12-31 | -$16.48M 10-K · filed 2018-03-01 | |||
| 2015-06-30 | -$4.64M 6-K · filed 2016-08-10 | -$7.72M 6-K · filed 2016-08-10 | ||
| 2014-12-31 | -$11.48M 20-F · filed 2017-02-21 | |||
| 2013-12-31 | -$2.43M 20-F · filed 2016-03-02 |